• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Celgene Corporation (CELG)

    -NasdaqGS
    120.87 Up 1.90(1.60%) 4:00PM EST
    |After Hours : 121.49 Up 0.62 (0.51%) 7:58PM EST
    Add to Portfolio
    Prev Close:118.97
    Open:119.57
    Bid:121.21 x 300
    Ask:N/A
    1y Target Est:125.17
    Beta:2.02
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:116.55 - 121.09
    52wk Range:66.85 - 124.60
    Volume:4,927,992
    Avg Vol (3m):5,145,100
    Market Cap:96.54B
    P/E (ttm):63.32
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 1.60%96.54B
    JNJUp 0.89%286.57B

    Key Statistics

    Forward P/E (1 yr):24.82
    P/S (ttm):12.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.69
    Quarterly EPS Est (Dec-14) :0.99
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback